Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - OPERATING EXPENSES
Operating Expenses YMAB - Y-mAbs Therapeutics, Inc.
99.1 M
LAST VALUE
-18.13%
2 YEAR CAGR
18.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR